Hemagen Diagnostics Inc (HMGN)

Hemagen Diagnostics Inc is a common stock listing on OTC Markets for a healthcare company focused on diagnostic products and services. The company develops, manufactures, and markets VIRGO, a line of human clinical immunoassays used in testing for autoimmune and infectious diseases as well as acute phase proteins. Its product range also includes human diagnostics components such as universal IFA materials, supplies, controls, calibrators, accessories, H-rotors, reagents, electrodes, equipment, and specialty assays including Chagas, acute phase proteins, and cytokines. Hemagen Diagnostics also provides veterinary diagnostic products spanning chemistry, hematology, and electrolyte applications. These products are used in laboratories, hospitals, and blood banks. The company was incorporated in 1985 and is based in Columbia, Maryland.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.